Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 71 - 80 out of 85

AMIA Comments on FDA Mobile Medical Apps Draft Guidance

October 19, 2011

AMIA recently issued comments in response to a U.S. Food and Drug Administration (FDA) draft guidance on mobile medical applications. In the comments, AMIA president Ted Shortliffe noted, among other things, the need for additional clarification, definitions, terms, and terminology in the guidance. Click below to read AMIA's full comments.

AMIA Identifies Areas to Strengthen Federal Health IT Strategic Plan

May 6, 2011

AMIA has weighed in on the Federal Health IT Strategic Plan in response to the HHS Office of the National Coordinator’s (ONC) call for comments on the overarching strategy for realizing health IT goals set forth by the U.S. Congress and the Administration. AMIA states in its comments to ONC […]

AMIA Comments on NINR Draft Strategic Plan 2011

March 17, 2011

AMIA submitted comments recently to the National Institute of Nursing Research (NINR) in response to their request for public comments on the latest draft of the Institute's strategic plan. The association's comments were informed by AMIA's Nursing Informatics Working Group (NIWG), which promotes the advancement of nursing informatics within the […]

AMIA Comments on Federal Health IT Standards Activities

March 7, 2011

Re: Request for Information Regarding the Effectiveness of Federal Agency Participation in Standardization in Select Technology Sectors for the National Science and Technology Council‘s Sub-Committee on Standardization.

Dear Dr. Gallagher:

On behalf of AMIA, I am pleased to submit these comments regarding NIST‘s recent request for information about the effectiveness […]

AMIA Comments to ONC on Meaningful Use Stage 2

February 26, 2011

Dear Dr. Seidman:

On behalf of AMIA (the American Medical Informatics Association), I am pleased to submit these comments in response to the above-referenced request for comment (RFC). AMIA is the professional home for biomedical and health informatics and is dedicated to the development and application of informatics in support […]

AMIA Board Position on Ethics: Vendor Values, Patient Safety and Best Practices

November 12, 2010

The current commercial health information technology (IT) arena encompasses a number of competing firms that provide electronic health applications to hospitals, clinical practices, and other healthcare-related entities. Such applications collect, store, and analyze patient information. Some vendors incorporate contract language whereby purchasers of health IT systems, such as hospitals and […]

AMIA Submits Comments to DEA on E-Prescribing Controlled Substances

May 29, 2010

AMIA comments to DEA on E-Prescribing Controlled Substances which would revise the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Controlled Substances Act, or CSA) and the related regulations to allow healthcare providers to write prescriptions for controlled substances electronically. These revisions would have to allow e-prescribing controlled substances […]

AMIA Comments on Proposed Establishment of Certification Programs for Health Information Technology

May 10, 2010

AMIA comments on the proposed establishment of the Certification Programs for health information technology (HIT). AMIA agrees with the distinction between “testing” and “certification,” and support the use of the International Organization for Standard (ISO) and the International Electrotechnical Commission (IEC) ISO/IEC Guides to structure how testing, certification, and accreditation […]